Parkman Healthcare Partners LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001777015

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2025 · 91 positions · Total reported value $958.70M · Top-10 concentration 33.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 68.0% · 26 new · 31 cut · 13 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.8% · vs SPY -4.9% · Prev Value $976.83M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.8% · vs SPY -4.0% · Latest Value $1.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, Parkman Healthcare Partners LLC disclosed 91 equity positions with a combined reported value of $958.70M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 33.0% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were QQQ ($48.03M), BSX ($42.41M), ALNY ($39.99M). By sector, the heaviest allocations are Health Care 76.8%, Technology 3.3%. Versus the prior quarter, allocation shifted toward Other (+4.1pp), Technology (+1.1pp) and away from Consumer Staples (-1.1pp), Health Care (-2.1pp).

Versus the prior quarter, Parkman Healthcare Partners LLC opened 26 new positions, trimmed 31 and fully exited 13, a turnover rate of 68.0% of positions. The portfolio's overlap with the prior quarter was 74% of names.

The largest new positions opened in Q3 2025 were QQQ ($48.03M), BIIB ($18.23M), ASMB ($6.43M).

Of the 13 positions fully exited versus the prior quarter, the largest were VRNA ($18.72M), RVTY ($15.20M), GILD ($14.60M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • QQQ INVESCO QQQ TR · $48.03M
  • BIIB BIOGEN INC · $18.23M
  • ASMB ASSEMBLY BIOSCIENCES INC · $6.43M
  • STOK STOKE THERAPEUTICS INC · $5.88M
  • MAZE MAZE THERAPEUTICS INC · $5.19M
  • ABVX ABIVAX SA · $4.69M
  • IMNM IMMUNOME INC · $4.11M
  • AGIO AGIOS PHARMACEUTICALS INC · $4.03M

Fully Exited (vs previous quarter)

  • VRNA VERONA PHARMA PLC · prev qtr: $18.72M
  • RVTY REVVITY INC · prev qtr: $15.20M
  • GILD GILEAD SCIENCES INC · prev qtr: $14.60M
  • MRUS MERUS N V · prev qtr: $8.57M
  • ANIP ANI PHARMACEUTICALS INC · prev qtr: $8.38M · history
  • REPL REPLIMUNE GROUP INC · prev qtr: $8.33M
  • DGX QUEST DIAGNOSTICS INC · prev qtr: $7.36M
  • ALKS ALKERMES PLC · prev qtr: $5.72M

Insider Transactions (Form 4)

Latest Parkman Healthcare Partners LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Parkman Healthcare Partners LLC, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 77 positions worth $976.83M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-114849 (status: Approved), registered 2019-03-15
  • Regulatory AUM (Form ADV): $1.74B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 77 positions · $976.83M reported value (Q2 2026)
  • Top 10 holdings = 33.5% of reported value
  • Largest position: MBX (MBX BIOSCIENCES INC COM) at 4.5%
  • Average position size: $12.69M

Sector Tilt

  • Health Care 92.1%
  • Consumer Staples 4.1%
  • Industrials 3.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 18 new, 25 added, 30 reduced, 31 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 76.8%
Technology 3.3%
Other 13.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 80.00K $48.03M 5.01%
5.01%
New
2 434.38K $42.41M 4.42%
4.42%
Add
3 87.69K $39.99M 4.17%
4.17%
Reduce
4 116.24K $35.89M 3.74%
3.74%
Add
5 379.49K $28.61M 2.98%
2.98%
Reduce
6 671.59K $26.08M 2.72%
2.72%
Add
7 1.15M $24.91M 2.60%
2.60%
Reduce
8 251.42K $24.76M 2.58%
2.58%
Add
9 64.11K $23.70M 2.47%
2.47%
Add
10 500.16K $22.35M 2.33%
2.33%
Hold
11 28.54K $22.05M 2.30%
2.30%
Add
12 110.54K $21.92M 2.29%
2.29%
Hold
13 1.74M $21.13M 2.20%
2.20%
Add
14 345.36K $20.16M 2.10%
2.10%
Reduce
15 141.82K $19.91M 2.08%
2.08%
Reduce
16 130.16K $18.23M 1.90%
1.90%
New
17 455.52K $17.27M 1.80%
1.80%
Reduce
18 843.50K $15.87M 1.66%
1.66%
Add
19 74.33K $15.09M 1.57%
1.57%
Reduce
20 1.79M $14.58M 1.52%
1.52%
Reduce
21 275.81K $14.45M 1.51%
1.51%
Add
22 773.30K $13.53M 1.41%
1.41%
Reduce
23 1.69M $13.30M 1.39%
1.39%
Add
24 178.97K $13.09M 1.37%
1.37%
Add
25 846.90K $13.03M 1.36%
1.36%
Reduce
26 202.36K $12.42M 1.29%
1.29%
Add
27 149.85K $12.30M 1.28%
1.28%
Reduce
28 155.77K $12.11M 1.26%
1.26%
Reduce
29 176.52K $12.10M 1.26%
1.26%
Reduce
30 306.03K $11.60M 1.21%
1.21%
Add
31 171.63K $11.55M 1.21%
1.21%
Reduce
32 475.57K $10.83M 1.13%
1.13%
Add
33 509.61K $10.45M 1.09%
1.09%
Hold
34 120.19K $10.39M 1.08%
1.08%
Hold
35 696.98K $10.13M 1.06%
1.06%
Add
36 221.04K $9.36M 0.98%
0.98%
Add
37 22.00K $9.22M 0.96%
0.96%
Add
38 501.83K $8.95M 0.93%
0.93%
Reduce
39 550.17K $8.92M 0.93%
0.93%
Reduce
40 652.68K $8.88M 0.93%
0.93%
Add
41 100.44K $8.52M 0.89%
0.89%
Add
42 339.76K $8.12M 0.85%
0.85%
Reduce
43 402.60K $8.03M 0.84%
0.84%
Add
44 40.34K $8.02M 0.84%
0.84%
Reduce
45 579.17K $7.87M 0.82%
0.82%
Reduce
46 1.01M $7.69M 0.80%
0.80%
Hold
47 223.06K $7.66M 0.80%
0.80%
Add
48 10.00K $7.63M 0.80%
0.80%
Reduce
49 252.82K $7.45M 0.78%
0.78%
Reduce
50 176.14K $7.07M 0.74%
0.74%
Add

FAQ

What did Parkman Healthcare Partners LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, Parkman Healthcare Partners LLC reported 91 equity positions worth $958.70M in aggregate; its largest disclosed positions were QQQ ($48.03M), BSX ($42.41M), ALNY ($39.99M).

How large is Parkman Healthcare Partners LLC's portfolio?

Parkman Healthcare Partners LLC reported $958.70M of long equity holdings across 91 positions as of 2025-Q3. Top-10 holdings account for 33.0% of reported value.

What is Parkman Healthcare Partners LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/parkman-healthcare-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →